@article{articlea5b05b10,
title   = {Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6–7 months of age: a phase 1/2 randomized trial},
author = {Sáez-Llorens, Xavier and Norero, Ximena and Mussi-Pinhata, Marisa Márcia and Luciani, Kathia and de la Cueva, Ignacio Salamanca and Díez-Domingo, Javier and Lopez-Medina, Eduardo and Epalza, Cristina and Brzostek, Jerzy and Szymański, Henryk and Boucher, François D. and Cetin, Benhur S. and De Leon, Tirza and Dinleyici, Ener Cagri and Gabriel, Miguel Ángel Marín and Ince, Tolga and Macias-Parra, Mercedes and Langley, Joanne M. and Martinón-Torres, Federico and Rämet, Mika and Kuchar, Ernest and Pinto, Jorge and Puthanakit, Thanyawee and Baquero-Artigao, Fernando and Gattinara, Guido Castelli and Arribas, Jose Manuel Merino and Amador, Jose Tomas Ramos and Szenborn, Leszek and Tapiero, Bruce and Anderson, Evan J. and Campbell, James D. and Faust, Saul N. and Nikic, Vanja and Zhou, Yingjun and Pu, Wenji and Friel, Damien and Dieussaert, Ilse and Lopez, Antonio Gonzalez and McPhee, Roderick and Stoszek, Sonia K. and Vanhoutte, Nicolas},
year = {2024},
doi = {10.1093/infdis/jiad271},
journal   = {The Journal of Infectious Diseases}
}